• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载姜黄素纳米结构脂质载体的部分水解人参皂苷修饰。

Curcumin-Loaded Nanostructured Lipid Carrier Modified with Partially Hydrolyzed Ginsenoside.

机构信息

College of Pharmacy, Gachon University, 191 Hambakmoero, Yeonsu-gu, Incheon, 21936, South Korea.

出版信息

AAPS PharmSciTech. 2019 Jul 12;20(6):252. doi: 10.1208/s12249-019-1467-z.

DOI:10.1208/s12249-019-1467-z
PMID:31300965
Abstract

The objective of the present study was to investigate the effect of partially hydrolyzed ginsenoside on the physicochemical properties and in vitro release of curcumin from phospholipid-based nanostructured lipid carrier (NLC). NLC formulas modified with partially hydrolyzed ginsenoside (NLC-PG) were prepared with different amounts of ginsenoside using the conventional hot-melt method. The average particle size of curcumin-loaded NLC-PG ranged from 150 to 200 nm, and polydispersity index was in the range of 0.101-0.177, indicating monodispersed particle size distribution. Optical microscopy showed no sedimentation or recrystallization of curcumin even at 10,000 μg/ml concentration as NLC-PG in distilled water, indicating significantly enhanced solubility. TEM image showed that the nanoparticles were monodispersed with a multilayered core/shell structure. X-ray diffraction and FTIR spectroscopy showed that curcumin was amorphous in the NLC-PG, and there was no interaction between curcumin and the excipients. In vitro release study using simulated gastric/intestinal fluid media revealed that the release rate (J) of curcumin from the NLC-PG increased as a function of the ginsenoside content in the lipid carrier. Moreover, the J of curcumin kept gradually increasing in the presence of lipase, whereas in the presence of viscozyme, it sharply increased until the ginsenoside content reached 9.09% and subsequently plateaued. Partially hydrolyzed ginsenoside increased the J of curcumin from curcumin-loaded NLC-PG and therefore may be useful for improving the bioavailability of curcumin.

摘要

本研究旨在探讨部分水解人参皂苷对姜黄素从基于磷脂的纳米结构化脂质载体(NLC)中理化性质和体外释放的影响。采用常规热熔法,用不同量的人参皂苷对 NLC 配方进行改性,制备部分水解人参皂苷(NLC-PG)。载有姜黄素的 NLC-PG 的平均粒径在 150 至 200nm 之间,多分散指数在 0.101 至 0.177 之间,表明粒径分布单分散。即使在 10000μg/ml 浓度下,NLC-PG 在蒸馏水中也没有显示出姜黄素的沉淀或重结晶,表明其溶解度显著提高。TEM 图像显示纳米颗粒呈单分散状态,具有多层核/壳结构。X 射线衍射和傅里叶变换红外光谱表明,姜黄素在 NLC-PG 中为无定形,姜黄素与赋形剂之间没有相互作用。使用模拟胃/肠液介质的体外释放研究表明,NLC-PG 中姜黄素的释放速率(J)随脂质载体中人参皂苷含量的增加而增加。此外,在存在脂肪酶的情况下,姜黄素的 J 逐渐增加,而在存在粘蛋白酶的情况下,J 急剧增加,直到人参皂苷含量达到 9.09%,随后趋于平稳。部分水解人参皂苷增加了载有姜黄素的 NLC-PG 中姜黄素的 J,因此可能有助于提高姜黄素的生物利用度。

相似文献

1
Curcumin-Loaded Nanostructured Lipid Carrier Modified with Partially Hydrolyzed Ginsenoside.载姜黄素纳米结构脂质载体的部分水解人参皂苷修饰。
AAPS PharmSciTech. 2019 Jul 12;20(6):252. doi: 10.1208/s12249-019-1467-z.
2
Ginsenoside improves physicochemical properties and bioavailability of curcumin-loaded nanostructured lipid carrier.人参皂苷改善载姜黄素纳米结构脂质载体的理化性质和生物利用度。
Arch Pharm Res. 2017 Jul;40(7):864-874. doi: 10.1007/s12272-017-0930-1. Epub 2017 Jul 15.
3
In Vitro Cytotoxicity and Bioavailability of Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin.载姜黄素的人参皂苷修饰的纳米结构脂质载体的体外细胞毒性和生物利用度。
AAPS PharmSciTech. 2019 Jan 23;20(2):88. doi: 10.1208/s12249-019-1295-1.
4
In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.载姜黄素纳米结构脂质载体的体内抗疟活性。
Curr Drug Deliv. 2019;16(10):923-930. doi: 10.2174/1567201816666191029121036.
5
Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.新型壳聚糖-N-乙酰半胱氨酸表面修饰的纳米结构脂质载体对姜黄素眼部给药性能的潜在优势。
Sci Rep. 2016 Jun 28;6:28796. doi: 10.1038/srep28796.
6
Effect of Lipid and Oil Compositions on Physicochemical Properties and Photoprotection of Octyl Methoxycinnamate-loaded Nanostructured Lipid Carriers (NLC).载辛基甲氧基肉桂酸酯的纳米结构化脂质载体(NLC)的脂质和油成分对其理化性质和光保护的影响。
J Oleo Sci. 2020;69(12):1627-1639. doi: 10.5650/jos.ess20093.
7
Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment.用于负载多种中药成分以治疗肝癌的透明质酸包被的纳米结构脂质载体
Pak J Pharm Sci. 2020 Jan;33(1):109-119.
8
Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.设计并评价载有类脂蛋白的姜黄素无蛋白纳米结构脂质载体的脑靶向性。
Int J Pharm. 2016 Jun 15;506(1-2):46-56. doi: 10.1016/j.ijpharm.2016.04.033. Epub 2016 Apr 16.
9
Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design.采用 Box-Behnken 设计法设计并优化姜黄素载纳米脂质载体系统。
Biomed Pharmacother. 2021 Sep;141:111919. doi: 10.1016/j.biopha.2021.111919. Epub 2021 Jul 17.
10
Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.用于眼部给药的马来酸噻吗洛尔和布林佐胺负载纳米结构脂质载体系统的制备与表征
Curr Drug Deliv. 2018;15(6):829-839. doi: 10.2174/1566523218666171129205626.

引用本文的文献

1
Ginseng Nanosizing: The Second Spring of Ginseng Therapeutic Applications.人参纳米化:人参治疗应用的又一春天。
Antioxidants (Basel). 2025 Aug 5;14(8):961. doi: 10.3390/antiox14080961.
2
Fabrication of Mastic Gum Resin Tethered Phospholipid Nanocarriers for the Evaluation and Enhancement of Anti-inflammatory and Anti-bacterial Effects.用于评估和增强抗炎及抗菌效果的乳香树脂 tethered 磷脂纳米载体的制备
Curr Pharm Des. 2025;31(23):1866-1876. doi: 10.2174/0113816128353794241225083428.
3
Overview of Nanocosmetics with Emphasis on those Incorporating Natural Extracts.
纳米化妆品概述,重点关注含有天然提取物的纳米化妆品。
ACS Omega. 2024 Aug 16;9(34):36001-36022. doi: 10.1021/acsomega.4c00062. eCollection 2024 Aug 27.
4
Nanostructured lipid carriers loaded with morellic acid for enhanced anticancer efficacy: preparation, characterization, pharmacokinetics and anticancer evaluation.负载羊肚菌酸的纳米结构脂质载体用于增强抗癌疗效:制备、表征、药代动力学及抗癌评价
Am J Cancer Res. 2024 Mar 15;14(3):1101-1120. doi: 10.62347/VBOX7111. eCollection 2024.
5
Ginsenoside modified lipid-coated perfluorocarbon nanodroplets: A novel approach to reduce complement protein adsorption and prolong circulation.人参皂苷修饰的脂质包被全氟碳纳米液滴:一种减少补体蛋白吸附并延长循环时间的新方法。
Acta Pharm Sin B. 2024 Apr;14(4):1845-1863. doi: 10.1016/j.apsb.2023.11.016. Epub 2023 Nov 14.
6
Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin.开发姜黄素纳米脂质载体配方的计算计算机模型。
Molecules. 2023 Feb 15;28(4):1833. doi: 10.3390/molecules28041833.
7
Long-term Survival, Tolerability, and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer.在不可切除的转移性结直肠癌患者中,一线贝伐珠单抗和 FOLFIRI 联合载姜黄素的人参皂苷修饰纳米脂质载体的长期生存、耐受性和安全性。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221105498. doi: 10.1177/15347354221105498.
8
Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies.人参皂苷作为双功能药物和纳米载体增强抗肿瘤治疗。
J Nanobiotechnology. 2021 Oct 15;19(1):322. doi: 10.1186/s12951-021-01062-5.
9
Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications.负载植物生物活性成分的创新给药系统:制剂方法与应用
Plants (Basel). 2021 Jun 18;10(6):1238. doi: 10.3390/plants10061238.
10
Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.用于静脉注射疏水性活性药物成分的非溶血性纳米乳剂的设计
Pharmaceutics. 2020 Nov 25;12(12):1141. doi: 10.3390/pharmaceutics12121141.